Spencer M, Miniño A, Warner M. Drug Overdose Deaths in the United States, 2001–2021 [Internet]. National Center for Health Statistics (U.S.); 2022 [cited 2023 Oct 24]. Available from: https://stacks.cdc.gov/view/cdc/122556
Understanding the Opioid Overdose Epidemic [Internet]. Center for Disease Control and Prevention; 2021 [cited 2023 Oct 24]. Available from: https://www.cdc.gov/opioids/basics/epidemic.html
Gomes T, Men S, Campbell TJ, Tadrous M, Mamdani MM, Paterson JM, et al. Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study. Chen RJ, editor. PLOS ONE. 2022;17(12):e0278508.
Article CAS PubMed PubMed Central Google Scholar
Guy GP, Zhang K. Opioid prescribing by specialty and volume in the US. Am J Prev Med. 2018;55(5):e153–5.
Article PubMed PubMed Central Google Scholar
Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007–2012. Am J Prev Med. 2015;49(3):409–13.
Article PubMed PubMed Central Google Scholar
Regueras Escudero E, López Guzmán J. Prescriptions of opioid medicines in Spain between 2019 and 2020: what medical specialities are prescribing them and in what indications. Multidiscipl Pain J. 2021 [cited 2024 Jan 22]; Available from: https://www.mpainjournal.com/Documentos/ArticulosNew/01-Art-6-ING_3_1.pdf
Kiang MV, Humphreys K, Cullen MR, Basu S. Opioid prescribing patterns among medical providers in the United States, 2003–17: retrospective, observational study. BMJ. 2020;29:l6968.
Ringwalt C, Gugelmann H, Garrettson M, Dasgupta N, Chung AE, Proescholdbell SK, et al. Differential prescribing of opioid analgesics according to physician specialty for medicaid patients with chronic noncancer pain diagnoses. Pain Res Manag. 2014;19(4):179–85.
Article PubMed PubMed Central Google Scholar
Weiner SG, Baker O, Rodgers AF, Garner C, Nelson LS, Kreiner PW, et al. Opioid prescriptions by specialty in Ohio, 2010–2014. Pain Med. 2018;19(5):978–89.
Chenaf C, Kaboré JL, Delorme J, Pereira B, Mulliez A, Zenut M, et al. Prescription opioid analgesic use in France: trends and impact on morbidity-mortality. Eur J Pain. 2019;23(1):124–34.
Article CAS PubMed Google Scholar
Schubert I, Ihle P, Sabatowski R. Increase in Opiate Prescription in Germany Between 2000 and 2010. Dtsch Ärztebl Int. 2013 [cited 2024 Jan 19]; Available from: https://www.aerzteblatt.de/10.3238/arztebl.2013.0045
Musazzi UM, Rocco P, Brunelli C, Bisaglia L, Caraceni A, Minghetti P. Do laws impact opioids consumption? A breakpoint analysis based on Italian sales data. J Pain Res. 2018;11:1665–72.
Article CAS PubMed PubMed Central Google Scholar
Wagemaakers FN, Hollingworth SA, Kreijkamp-Kaspers S, Tee EHL, Leendertse AJ, Van Driel ML. Opioid analgesic use in Australia and The Netherlands: a cross-country comparison. Int J Clin Pharm. 2017;39(4):874–80.
Kalkman GA, Kramers C, Van Dongen RT, Van Den Brink W, Schellekens A. Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. Lancet Public Health. 2019;4(10):e498–505.
Dzierżanowski T, Ciałkowska-Rysz A. Accessibility of opioid analgesics and barriers to optimal chronic pain treatment in Poland in 2000–2015. Support Care Cancer. 2017;25(3):775–81.
Agencia Espanola de Medicamentos y Productos Sanitarios. Utilización de medicamentos opioides en España durante el periodo 2008–2015 [Internet]. 2017 Feb [cited 2024 Jan 19] p. 3. (Informe De Utilización De Medicamentos). Report No.: U/OPI/V1/13022017. Available from: https://www.aemps.gob.es/medicamentosUsoHumano/observatorio/docs/opioides-2008-2015.pdf
Jani M, Birlie Yimer B, Sheppard T, Lunt M, Dixon WG. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study. Song Z, editor. PLOS Med. 2020;17(10):e1003270.
Article PubMed PubMed Central Google Scholar
Nissen SK, Pottegård A, Ryg J. Trends of opioid utilisation in Denmark: a nationwide study. Drugs - Real World Outcomes. 2019;6(4):155–64.
Article PubMed PubMed Central Google Scholar
Zin CS, Chen L-C, Knaggs RD. Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain. 2014;18(9):1343–51.
Article CAS PubMed PubMed Central Google Scholar
Wertli MM, Reich O, Signorell A, Burgstaller JM, Steurer J, Held U. Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims. BMC Health Serv Res. 2017;17(1):167.
Article PubMed PubMed Central Google Scholar
Kurdi A. Opioids and gabapentinoids utilisation and their related-mortality trends in the United Kingdom primary care setting, 2010–2019: a cross-national, population-based comparison study. Front Pharmacol. 2021;14(12):732345.
Burgstaller JM, Held U, Signorell A, Blozik E, Steurer J, Wertli MM. Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use—A health insurance claims analysis. Suppiah V, editor. PLOS ONE. 2020;15(9):e0238285.
Article CAS PubMed PubMed Central Google Scholar
Gjersing L, Amundsen E. Increasing trend in accidental pharmaceutical opioid overdose deaths and diverging overdose death correlates following the opioid prescription policy liberalization in Norway 2010–2018. Int J Drug Policy. 2022;108:103785.
Hooijman MF, Martinez-De La Torre A, Weiler S, Burden AM. Opioid sales and opioid-related poisonings in Switzerland: A descriptive population-based time-series analysis. Lancet Reg Health - Eur. 2022;20:100437.
Article PubMed PubMed Central Google Scholar
Bickel W, Stitzer M, Liebson I, Bigelow GE. Acute physical dependence in man: Effects of naloxone after brief morphine exposure. J Pharmacol Experiment Therapeut. 1988;244(1):126–32.
Kirby KC, Stitzer ML. Opioid physical dependence development in humans: effect of time between agonist pretreatments. Psychopharmacology. 1993;112(4):511–7.
Article CAS PubMed Google Scholar
Heishman S, Stitzer M, Bigelow G, Liebson I. Acute opioid physical dependence in humans: Effect of varying the morphine-naloxone interval. J Pharmacol Experiment Therapeut. 1989;250(2):485–91.
Sandbrink F, Uppal R. The time for opioid stewardship is now. Jt Comm J Qual Patient Saf. 2019;45(1):1–2.
The Lancet Regional Health – Americas. Opioid crisis: addiction, overprescription, and insufficient primary prevention. Lancet Reg Health - Am. 2023;23:100557.
PubMed PubMed Central Google Scholar
Schug SA. Opioid stewardship can reduce inappropriate prescribing of opioids at hospital discharge. Med J Aust. 2020;213(9):409–10.
Michalowski A, Boateng S, Fraser MR, Levine RL. Developing a Culture of Opioid Stewardship: The Pennsylvania Example. In: A public health guide to ending the opioid epidemic [Internet]. Oxford University Press; 2019 [cited 2024 Mar 14]. p. 307–22. Available from: https://academic.oup.com/book/32440/chapter/268773901
Khorfan R, Shallcross ML, Yu B, Sanchez N, Parilla S, Coughlin JM, et al. Preoperative patient education and patient preparedness are associated with less postoperative use of opioids. Surgery. 2020;167(5):852–8.
Kushner BS, Tan WH, Sehnert M, Jordan K, Aft R, Silviera M, et al. Assessment of postoperative opioid stewardship using a novel electronic-based automated text and phone messaging platform. Surgery. 2021;169(3):660–5.
Coulson EE, Kral LA. The Clinical Pharmacist’s Role in Perioperative Surgical Pain Management. J Pain Palliat Care Pharmacother. 2020;34(3):120–6.
Langford AV, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, et al. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Med J Aust. 2023;219(2):80–9.
Hamilton M, Kwok WS, Hsu A, Mathieson S, Gnjidic D, Deyo R, et al. Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines. Pain. 2023;164(3):485–93.
Sullivan MD. Opioid deprescribing guidelines and consumer preferences: betwixt and between. Pain. 2021;162(11):2625–6.
Nelson LS, Mazer-Amirshahi M, Perrone J. Opioid Deprescribing in Emergency Medicine—A Tool in an Expanding Toolkit. JAMA Netw Open. 2020;3(3):e201129.
留言 (0)